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Introduction 
Obesity in the US has become a significant public health concern in recent decades, with 
current data showing nearly 40% of American adults having a BMI over 30.25 Many factors have 
been attributed to the increasing prevalence of obesity, including alterations in the food 
environment and supply, availability of physical activity in schools and neighborhoods, changes 
in social norms, increased availability of technology and screen time, medication use, changes in 
sleep habits, evolutionary adaptation, social networks and interpersonal interactions, individual 
genetic polymorphisms and predisposition, individual microbiome differences, and exposure to 
toxins.57,58,60 However, an extremely significant but often-overlooked pathophysiological factor 
linked to obesity and changes in metabolic functioning in adulthood is childhood trauma.  
 Stressful experiences activate psychological and physiological responses that are 
designed to be adaptive, readying the individual to respond to the stimuli in the appropriate 
manner, the “fight or flight” response. For the developing child, these experiences may be 
positive, when they teach resilience and control. They may be tolerable, where the effects are 
negative but the individual has adequate time and support to recover.45 Or they may be toxic, 
defined by the American Academy of Pediatrics (AAP) as “strong, frequent, or prolonged 
activation of the body’s stress systems in the absence of the buffering protection of a supportive 
adult relationship”.47 The plasticity of the infant and child brain places it at higher risk of being 
impacted by the effects of toxic stress. Chronic activation of the body’s stress pathways is 
thought to alter multiple regions of the brain, including the amygdala, hippocampus, and 
prefrontal cortex.47 Structural as well as chemical changes occur that alter the maintenance of 
homeostasis in the body, changes that are known as “allostatic load”.31 This dysregulation may 
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result in the disruption of a number of functions in the body through alterations in signaling 
activity and the subsequent disorders this can generate.30,31 
 Inspired by an initial study that showed variables related to familial and childhood trauma 
may be linked to success or failure in a weight loss program for adults with obesity,16 Felitti et al. 
developed the landmark “ACEs study” through a collaboration between the CDC and Kaiser 
Permanente. This publication defined childhood trauma using 7 categories of adverse childhood 
experiences, or “ACEs”, individual level measures of toxic stress. These included psychological, 
physical, or sexual abuse, violence against a child’s mother, living with family members who 
had substance abuse, mental illness, or suicidality, or having family members who had ever been 
imprisoned. The sum of these exposures generates an “ACE score”, a quantitative measure of 
childhood trauma. Through questionnaire administration to a sample of 8,056, mostly white, 
educated adults aged 19-92, the initial study demonstrated a number of unanticipated findings, 
confirmed in future waves of participants. A higher prevalence of childhood trauma was seen 
than expected; over 50% of people reported at least one ACE, and for those who reported one, 
the median probability of exposure to another was 80%.17 There was a strong relationship 
demonstrated between childhood ACE exposure and a clustering of risk factors for the leading 
causes of mortality. Risk factors studied included smoking, severe obesity, physical inactivity, 
depression, suicide attempts, and alcohol or drug abuse, among others. The analysis also 
measured the relationship between childhood exposure and disease outcomes including ischemic 
heart disease, stroke, cancer, chronic bronchitis, COPD, diabetes, hepatitis or jaundice, skeletal 
fractures, and perceived health status. A strong dose-response relationship was seen for most of 
the interactions, with higher ACE score generating a much greater risk of the outcome. For 
severe obesity in particular, prevalence increased significantly with exposure to a greater number 
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of ACE categories. Those with an ACE score of four or higher had 1.6 times the odds of being 
obese than those with an ACE score of zero, even with adjustment for age, gender, race, and 
education.17  
Later studies have built on the association of trauma and obesity, expanding the scope of 
the exposure variable to include social isolation,12 socioeconomic status measured through parent 
educational attainment,48,49 psychosocial stressors including both household and individual level 
variables,24 and PTSD.5 The majority of these studies attempted to isolate the effect of childhood 
trauma on obesity by controlling for various other factors; parental weight status, geographic 
area, demographic variables, adult behavior and lifestyle, and family history, and all found that a 
persistent association remained. Davis et al. evaluated the risk of both central and overall obesity 
as predicted by a more nuanced definition of childhood adversity including number of 
adversities, chronicity, and severity. Defined in this manner, childhood adversity continued to be 
a significant predictor of central obesity, even when negative health behaviors adopted in 
adulthood and psychosocial factors such as education, employment, and social capacity were 
considered.13 The cumulative findings of these studies indicate the presence of certain 
independent, biological consequences of childhood trauma that may be altered but not 
overridden by other factors.  
The epidemiological study of the association between childhood trauma and obesity is 
supported in part by studies of the neuroendocrine and biochemical mechanisms underlying the 
stress response. Research has gradually elucidated the role of the hypothalamic pituitary adrenal 
axis (HPA axis), and the associated glucocorticoid (GC) release in response to stressful stimuli. 
A number of conditions associated both with increased and decreased levels of HPA axis activity 
provide some initial insight into disruption of homeostasis. Cushing’s disease, clinically defined 
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by hypercortisolemia, is usually associated with impaired glucose tolerance, obesity and altered 
distribution of adipose tissue along with fatigue and hypersomnia.6,8,11 Anxiety and mood 
disorders have been associated with increased corticotropin releasing hormone (CRH) and 
peripheral cortisol, though the latter may also sometimes be decreased as well.40 Melancholic 
depression is associated with not only higher CRH secretion and urinary cortisol levels, but also 
decreased response to exogenous CRH.37 Anorexia nervosa, characterized by altered energy 
intake and associated with anxiety and obsessive-compulsive disorder, is also associated with 
increased HPA axis activity, alongside decreased activity of the sympathetic nervous system.40 
The mechanisms of these associations, and the specific neuronal pathways that stimulate the 
HPA axis activity in each appear to be slightly different. However, they demonstrate clinically 
multiple links between altered HPA axis activity, mental health, and energy intake and storage.  
Study of these conditions complements progress in understanding the physiological 
response to stress through HPA axis dysregulation in human and non-human model systems. Yet 
there is still much that remains to be unraveled in the stress response and how knowledge of it 
may be leveraged for practical applications in the realms of policy, public health, and 
preventative medicine. 
Using the model for a scoping review of the literature proposed by Arksey and 
O’Malley,3 this summary proposes to map the neuroendocrine response to stress, describing what 
is known about the stress-induced activation of the HPA axis. Subsequent GC feedback on this 
system, its action on peripheral tissues, and some of the hormonal signals that peripheral tissues 
use to communicate with it will also be examined. Some of these signals also play a role in 
homeostatic regulation of feeding, which will be addressed briefly. Though hedonic regulation of 
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feeding is likely also altered with exposure to toxic stress, and homeostatic and hedonic control 
appears to exhibit some overlap,44 hedonic regulation will not be explored here.  
One of the challenges facing the study of the toxic stress mechanism is developing an 
appropriate model in which to replicate and understand phenomena. HPA axis measurement and 
manipulation in rodents has revealed much about the physiological response to stressful stimuli, 
but the translation to child development is not always straightforward. In order to bridge this gap, 
an additional goal of this paper will be to identify directions for future research and practice by 
highlighting the measurement methods and clinically relevant biomarkers used in mechanistic 
studies. 
 
Methods 
After identification of the area of interest, the research question was narrowed to: “What 
is the role of the HPA axis and its hormonal inputs and outputs in the relationship between stress 
and obesity?” Relevant literature was identified through the PubMed, Google Scholar, and 
Cochrane Review databases. Literature searching was conducted between the months of January 
of 2017 and September 2018. To encompass a broader perspective on the research question, 
sources included a variety of formats; original research publications, systematic reviews, meta-
analyses, narrative reviews, and policy statements. Search terms such as adverse childhood 
experience, ACE, childhood trauma, toxic stress, metabolism, obesity, neuroendocrine, HPA 
axis, and glucocorticoids were used to identify relevant papers, and their references were mined 
for additional resources.  
 Following the third stage of the Arksey and O’Malley framework,3 inclusion criteria were 
developed after the background literature had been explored. For the exposure variable, literature 
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was excluded if it addressed adult PTSD, pre-natal or maternal stress, but other stressors were 
allowed, including those induced in lab conditions in rodents or human subjects and those 
measured in human populations through surveys of perceived stress or biomarkers. Interpersonal 
as well as physical stressors were considered, the latter used more frequently in rodent studies. 
Stress exposure was not limited to an early childhood time frame. For the outcome variable, 
literature that examined metabolic conditions or disease states other than overall or central 
obesity, such as metabolic syndrome or type 2 diabetes mellitus, were excluded unless it 
separated out analysis of obesity. Literature examining differences among types of adipose tissue 
was considered. Not all mechanisms related to obesity development were included; only 
references with relevance to the HPA axis and the homeostatic factors that interact with it and 
regulate it were included. Only English papers or reports were included. Resources published 
prior to the year of the original ACEs study, 1998, were only included for background research, 
given that the quantifiable definition of trauma and the scope of the ACE-obesity association had 
yet to be developed.  
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Figure 1: Arksey and O’Malley framework (left) and steps taken for this review (right). 
 
Results 
This review will outline the central pathways of HPA axis activity, and subsequent peripheral 
glucocorticoid (GC) action. Hormonal signals from the periphery including insulin, ghrelin, and 
leptin will also be described, as they can transmit information about energy status to the HPA 
axis, regulate food intake, and their levels may be altered by HPA axis activity. Neuropeptide Y 
(NPY), a neuropeptide released centrally when the stress system is activated, will be addressed, 
as it interacts with both the HPA axis, GCs, and these peripheral hormonal signals.  
• Stress or trauma narrowed to the level of the individual
• Metabolic outcomes narrowed to measures of weight status and adiposity 
• Biological pathways examined narrowed to the HPA axis and its hormonal inputs and outputs
Stage 1: Identifying the 
research question
•Mechanistic studies were chosen if published after the original ACEs study emerged (1998)
•Only papers published in peer reviewed academic journals were chosen, but a range of formats was accepted
•Only English language papers were reviewed
•PubMed, Cochrane Review, Google Scholar databases were searched based on the relevance and number of 
results identified through these databases
•Reference lists in selected papers were used to identify additional resources
•Hand searching journals and existing networks or conferences was not done due to time restraints
Stage 2: Identifying 
relevant studies
• Inclusion criteria were developed – stress exposure and obesity outcome, homeostatic, HPA 
axis-related mechanisms selected
• 24 articles were selected for the background research, 16 for section 1, 14 for section 2, and 
15 for section 3.
Stage 3: Study selection
• Data from relevant studies was recorded in a narrative manner
• Date, location, title, author, and type of study was documented
• Relevant methods and results were summarized for each resources
Stage 4: Charting the 
data
• Results from relevant studies were included in the review based on relevance to the 
proposed research question 
• Related mechanistic details were grouped from different resources for organizational 
purposes
Stage 5: Collating, 
summarizing and 
reporting the results
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Figure 2: Schematic depiction of the results of stress on the HPA axis, SNS (sympathetic nervous system), NPY (neuropeptide Y), 
GC (glucocorticoid) response via MR/GRs (mineralocorticoids and glucocorticoids), GNG (gluconeogenesis), IR, glucose 
uptake, ghrelin, insulin, angiogenesis in adipose tissue, LPL (lipoprotein lipase activity), VAT to SAT ratio (visceral adipose 
tissue to subcutaneous adipose tissue) and leptin.    
Central pathways of the HPA axis 
HPA axis activation  
The central response to stressful stimuli as activated largely through two parallel 
mechanisms: activation of the HPA axis and of the sympathetic nervous system (SNS). Broadly, 
the HPA axis accepts and relays signals that impact the intermediate and long-term response to 
stress, while the SNS mediates the acute response to stress, the “fight or flight” response. The 
SNS acts primarily through the release of catecholamines from the adrenal medulla that work 
complementarily to increase metabolic rate, redirect blood flow from nonessential organs, and 
raise blood glucose.28,42 There is some cross-talk between the HPA axis and SNS responses. 
GCs, the end product of the HPA axis activation, enhance the release of NPY, secreted from both 
GCs
+ MR/GR
SNS
NPY
Stress axis activity
Other peripheral tissues
Increased GNG in liver
Decreased glucose uptake
Decreased insulin receptor function (IR)
Ghrelin
Insulin 
Central 
Regulation and 
Integration
Adipose tissue
Increased angiogenesis
Increased LPL activity
VAT:SAT ratio
Leptin
Hypothalamus
Pituitary 
Adrenals
CRH
ACTH 
Peripheral 
effects
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the hypothalamus and sympathetic neurons. NPY in turn inhibits the SNS.9,42 It is primarily the 
HPA axis, however, and not the SNS, that is implicated in the relationship between stress and 
obesity.  
 The HPA axis consists of cell populations in three locations, the hypothalamus, the 
pituitary gland, and the adrenal gland, that interact with each other via chemical signaling.51 The 
role of the hypothalamus, where the response to stress is captured and relayed, is to maintain 
homeostasis through central regulation of the endocrine response. There, circadian input is 
received from the suprachiasmatic nucleus, sensory stimuli is transmitted, hedonic control of 
feeding occurs via the mesolimbic system, which includes multiple regions of the brain, and 
hormonal and chemical signals from the peripheral tissues converge.26  
The hypothalamus is divided into different nuclei with separate but sometimes 
overlapping functions. The paraventricular nucleus, or PVN, is the main intersection for the 
stress response. PVN neurons stimulated by stress release CRH, arginine vasopressin (AVP), or 
both.9 CRH travels through the hypophyseal portal system to the anterior pituitary, where it 
stimulates the release of adrenocorticotropic hormone (ACTH).26 ACTH travels through the 
bloodstream to the adrenal glands, located on top of the kidneys. In the adrenal cortex, where 
GCs are synthesized, ACTH interaction with melanocortin 2 receptors causes GC secretion.26, 42 
GCs travel in circulation bound to a corticosteroid binding globulin (CBG), made in the 
liver. The two have a high affinity for each other such that over 90% of GCs are bound to 
CBG.51 GCs act in peripheral tissues through their binding to glucocorticoid receptors (GRs) and 
mineralocorticoid receptors (MRs).8 Their ability to do so, however, is determined by several 
isoforms of an enzyme that convert between metabolites. 11-Beta-hydroxysteroid dehydrogenase 
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1 (11-BHSD1) converts cortisone, the inactive form, to cortisol, which can bind the MR or GR, 
while 11-Beta-hydroxysteroid dehydrogenase 2 converts it back to the inactive form. 
 
Feedback regulation of HPA axis activity 
To prevent excessive continual secretion of hormonal signals and to return the system to 
a homeostatic state after stimulation, there are multiple negative feedback mechanisms on the 
HPA axis.32 Generally, feedback can be characterized by the duration of time between a stimulus 
and its action. Because the GR and MR are part of the steroid hormone receptor family, they 
predominantly act through binding of a ligand, translocation to the nucleus, and binding of a 
response element or other region of DNA, altering levels of mRNA and the translation of 
subsequent proteins.  
Feedback initiated by this process is thus relatively slow, acting over a time frame of 
minutes to hours. Negative feedback first inhibits the proteins involved in secretion of ACTH 
and CRH, then on the synthesis of these components. It has been shown to be proportional to the 
amount of GC and intensity of the stressor, though different stressors do not seem to produce the 
same feedback response, indicating differences in how these stressors are interpreted or 
signaled.32  
Another type of feedback, occurring on a faster time frame, has been well demonstrated 
in rodent models, but is less replicable in humans. It happens in seconds to minutes, and it is rate 
sensitive; it depends on the concentration of GCs being released. The mechanism appears to be 
mediated through membrane bound GRs or MRs in the hypothalamus and hippocampus that 
activate cell signal transduction pathways rather than through steroid hormone binding, and it 
inhibits CRH and ACTH secretion but not synthesis.32  
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The pathways with which GC release feeds back on HPA axis activity are important to 
understand when considering toxic stress exposure in children. With repeated HPA axis 
stimulation, there can be habituation and decreased activity if the exposure is continually 
repeated or enhancement of activity if the exposures are heterogeneous.32 In mice exposed to 
acute stress, plasma GCs rose initially but returned to baseline after two weeks of continued 
exposure, or when stress was combined with a calorie dense diet.33 Rats exposed to restraint 
stress respond with both higher ACTH and GCs when exposed to novel acute stress.27 Certain 
conditions, including depression, are associated with decreased feedback in response to GC 
level. Finally, peripheral conditions may also impact HPA axis feedback; mice with genetically 
reduced GR expression in their adipocytes had reduced sensitivity to inhibition of the HPA axis, 
and secreted higher levels of GCs sooner after inhibition of the GR when exposed to stressful 
stimuli.14  
 
Basal versus stress induced HPA activity 
The HPA axis has basal fluctuations in activity that cause changes in ACTH and GC 
levels on both an hourly (ultradian) and daily (circadian) basis. For humans, peak activity tends 
to occur around dawn and approximately half an hour after waking.51 Though basal fluctuation is 
important to consider when attempting to measure GC or ACTH experimentally, the changes in 
response to stressful stimuli tend to have a much greater magnitude. Acute stress exposure 
causes doubling or more of both rat and human levels of ACTH and cortisol or corticosterone, 
the rat analog of cortisol.51 
 
Measurement of HPA axis activity  
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There are multiple biomarkers capable of reflecting HPA axis activity; they differ in ease 
of collection, sensitivity, and ability to manipulate experimentally. Serum or plasma GC 
measurement, in micrograms per milliliter, is widely used in rodent studies, but risks 
confounding due to the stress of sampling methods, which include indwelling catheters and tail 
vein sampling.51 ACTH blood levels may also be measured in rodents, in picograms per 
milliliter. They are more sensitive to stimuli and able to localize changes to the level of the 
pituitary, but as a peptide rather than steroid hormone, ACTH is less stable and requires greater 
blood volume.51 Additionally, levels of mRNA may be measured to indicate gene expression, 
and adrenal gland weight can indicate up or downregulation of ACTH and ACTH synthesizing 
and secreting machinery.51  
In humans, blood measures of cortisol are possible but subject to some of the same 
limitations as for rodents. The most commonly used are 24-hour urinary free cortisol and 
salivary cortisol, though hair cortisol may also be measured to estimate cortisol levels over a 
several month period.8,38 Urinary cortisol is inconsistently different between non-obese and 
obese subjects, and it is unable to be measured at multiple times throughout the day as salivary 
cortisol is, meaning that it isn’t able to capture basal fluctuation, but it can represent a slightly 
longer time frame.8 Salivary cortisol, in contrast, is used most often to study response to an acute 
stressor through saliva sampling at baseline and periodic intervals after exposure extending 
usually no more than two hours.  
 The most common method for manipulating HPA axis activity in humans is through 
administration of dexamethasone. A GR agonist, it can be used to test the function of the 
feedback system.52 However, because low doses are not able to cross the blood brain barrier, it 
measures feedback primarily at the level of ACTH inhibition rather than CRH releasing 
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neurons.51 In rodents, cortisol can be manipulated through delivery of exogenous GCs by 
implanted pellets, drinking water, or injections, and generation of stressful experiences to 
increase endogenous GCs.51 Stress induction has the significant advantage of being able to 
indicate directionality in relationships between stimuli and HPA axis response. 
This level of control is, understandably, limited in human studies. Some have avoided 
this barrier by sampling from those who had experienced a traumatic motor vehicle accident,41 
though the challenges inherent in recruitment limits sample size. Others have induced social 
stress through a combination of a mock job interview and mental arithmetic test,59 yet the ability 
of such activities to replicate toxic stress is questionable. Additionally, there may be factors that 
modulate the human perception of stress (e.g. social or environmental supports) that are not 
replicable in rodents.  
In studying the relationship between HPA axis activity and obesity, another challenge is 
that of food intake and weight change in response to stress. One meta-analysis found that 
psychosocial stress was associated with weight gain,56 and a longitudinal cohort study using BMI 
self-report found that stress was associated with weight gain in those with higher BMI.7 In rats 
and mice, however, weight loss in response to stress with elevated corticosterone is consistent.27 
This could reflect the food environment to which study animals are exposed, which generally 
consists of standard chow, unlike a human diet that may vary in quantity of high fat and high 
sugar foods from individual to individual. It could also reflect differences in energy expenditure 
mediated by different levels of brown adipose tissue in rodents versus humans.27 Regardless, it 
requires that in order for rodents to serve as a model for human weight gain with stress, their diet 
or their genetic susceptibility must be altered.  
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Hamsters, unlike rats and mice, secrete both cortisol and corticosterone, and these appear 
to be regulated differently in response to stress.39 Primates also secrete cortisol, and display some 
similar eating behaviors to humans in response to social stress2. Though more difficult to obtain, 
these qualities make both of these models promising compared to rats or mice.27  
To study the action of the HPA axis activity on peripheral tissues, cell cultures provide 
another model system. Human adipocytes may be selected either from established cell lines or 
from surgically generated samples.20,34,35 Pre-adipocytes have been used to study adipocyte 
differentiation in both mouse and human cells, but there is some debate over compatibility of 
these two models and concern that methodology may yield conflicting results.4,34 Within cell 
samples, protein levels of GRs or MRs can be measured via Western blotting, and mRNA 
expression of various genes in both peripheral and central tissues can be measured using 
complementary DNA and polymerase chain reaction (PCR) techniques. Because they are peptide 
hormones, leptin, adiponectin, and insulin levels may be measured relatively easily in blood 
samples from live subjects using ELISA assays, samples which can also be used to establish 
other metabolic biomarkers including triglycerides, high- and low-density lipoproteins, total 
cholesterol, and blood glucose levels.  
Measure Model system Window of 
measurement 
Strengths Limitations 
Plasma or serum 
glucocorticoid 
(cortisol or 
corticosterone) 
Humans, rodents, 
non-human primates 
Minutes to hours 
after exposure 
Measures immediate 
response to stressful 
stimuli, steroid 
hormones are stable 
in blood samples 
Subject to basal 
fluctuations and 
may be confounded 
by sampling-
induced stress 
Salivary cortisol  Humans  Minutes to hours 
after exposure  
Reflects free levels 
to which tissues are 
exposed, easily 
sampled outside of 
the laboratory 
setting 
Subject to basal 
fluctuations and 
does not reflect 
chronic stress 
24-hour urinary free 
cortisol 
Humans 24 hours  Easily measured 
clinically, provides 
a daily average 
estimate of exposure 
Does not reflect 
acute fluctuations, 
inconsistent 
between obese and 
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non-obese 
individuals 
Hair cortisol  Humans  Several months, 
depending on 
sample length 
(approximately 1 
cm growth occurs 
per month) 
Measures chronic 
stress over a longer 
time period, easily 
sampled without 
inducing stress   
Does not reflect 
immediate HPA 
axis response 
Plasma or serum 
ACTH  
Humans, rodents Minutes to hours 
after exposure 
Demonstrates the 
level of the activity 
(e.g. not only 
directly at the 
adrenals), more 
sensitive to stimuli 
than glucocorticoids 
Subject to basal 
fluctuations, assays 
need a larger blood 
volume than for 
glucocorticoids, 
peptide hormones 
are less stable than 
steroid hormones in 
blood samples 
PVN neuronal 
activation 
Rodents Minutes to hours 
after exposure 
Can be used for 
identification of 
gene expression and 
upstream signaling 
activity 
May not always 
clearly indicate 
downstream effects, 
analysis requires 
more complex 
laboratory 
techniques 
Table 1: Comparison of selected biomarkers of HPA axis activity 38,51,52 
 
Peripheral effects of HPA axis activity 
Metabolic effects of GCs  
The effects of GCs on metabolism can generally be considered catabolic, counteracting 
the effects of insulin to mobilize available fuel sources. To raise blood glucose, they stimulate 
gluconeogenesis in the liver and induce breakdown of muscle protein.28 Lipolysis is stimulated in 
adipose tissue, likely through activation of adipose triglyceride lipase and hormone-sensitive 
lipase (HSL), the latter being a main regulated enzyme in releasing free fatty acids from stored 
triglycerides.20, 36  These catabolic processes seem counterintuitive to a connection with obesity 
when considered in isolation, but become less straightforward when other interacting factors like 
the nutrient environment, as measured by the presence of insulin, chronic stress exposure, and 
existing obesity are evaluated.   
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The magnitude of the catabolic effects is dependent on insulin levels and location of 
activity. In cultured human adipocyte samples, no insulin and high GCs stimulated lipolysis and 
decreased lipogenesis as expected. But when insulin was high and GCs were also present in the 
adipocyte environment, expression of fatty acid synthase and one of the isoforms of acetyl co-A 
carboxylase were increased, indicating possible promotion of de novo lipogenesis.20  
Lipoprotein lipase (LPL), key in transferring free fatty acids from circulating 
chylomicrons and VLDL and thus increasing energy storage, also has increased expression in the 
presence of GCs. The presence of insulin and GCs together has a synergistic effect on LPL 
expression, and levels of expression further vary depending on type of adipose tissue.19, 36 
Centrally, the interaction of insulin with its receptors throughout the hypothalamus has been 
shown to impact the ability of the HPA axis to respond to negative feedback when exposed to 
stress.10 Through hypothalamic insulin receptor knockout studies, Chong et al. hypothesized that 
the nutrient status, as signaled from the periphery, may play a role in the stress response.10  
GCs are also necessary for the differentiation of preadipocytes into mature adipocytes, 
and though their means of regulating the functioning and activity of adipose tissue are not fully 
characterized, they have been shown to impact expression of up to 20% of adipose-specific 
genes.36 In considering a stress-stimulated mechanism for obesity, the coordinated interactions of 
insulin and GCs on lipid metabolism, the location of the GC action either in the vascular system 
for LPL or intracellularly for HSL, the type of adipose tissue, and the duration of the stress are 
all introduced as factors that may shift the balance between lipolysis and lipogenesis.  
 
GCs and abdominal obesity   
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Studies of the association of cortisol levels and obesity have established that the 
relationship is not entirely straightforward.36 GCs are associated specifically with accumulation 
of visceral adipose tissue (VAT), or the adipose tissue that is found within the abdomen 
surrounding the internal organs. VAT is divided into omental and mesenteric type depending on 
its location.36 Alternatively, subcutaneous adipose tissue (SAT) is found just under the surface of 
the skin. An association between VAT and GCs is demonstrated in the clinical manifestations of 
Cushing’s disease, where VAT accumulates and SAT wastes.36 Yet the measurement of cortisol 
levels in obese populations has shown mixed results. Some have found higher cortisol levels in 
obese or overweight individuals than in non-obese individuals,55 but this is not consistent across 
studies, and it appears that while local levels may be elevated, this does not always translate 
systemically.36 On the local level, VAT has been linked with altered GC turnover, independent 
of BMI.53 And VAT may alter HPA axis feedback as well. Cortisol measurement in monkeys 
after administration of dexamethasone has revealed that higher VAT to SAT ratio is associated 
with decreased sensitivity to the negative feedback that should have been induced.46  
There is also evidence that GCs increase intake, and in particular intake of foods that are 
high in sugar and fat. George et al. tested the effects of CRH administration on consumption 
without a stressor present, to attempt to isolate the impact of GCs. They found that peak cortisol, 
resulting from CRH administration, was significantly associated with total intake, measured in 
both grams and calories. Though it is possible that the elevated cortisol is a marker for some 
other factor rather than the cause of increased intake, and the sample size was small, the results 
imply that GCs not only stimulate VAT generation, but maintain its presence through increased 
consumption of calorie dense foods.21  
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Depot-specific differences in GC availability  
In developing understanding of the relationship between GCs and adiposity, some have 
focused on GC metabolism in different types of adipose tissue, as levels of 11-BHSD1 are tissue 
specific.35,53 Accordingly, GC signaling is regulated not only on the central but also the 
peripheral level.26 Obesity is associated with a reduction in liver activity of the enzyme and 
increase in adipose tissue activity.26 Within types of adipose tissue, Lee at el. found that levels of 
11-BHSD1 mRNA in cultured human adipocytes did not significantly differ between omental 
and subcutaneous abdominal adipose tissue, but 11-BHSD2 mRNA was significantly higher in 
omental adipose tissue.35 This strengthens the hypothesis that VAT has higher turnover of 
cortisol, and the authors suggest that this local change occurs in order to prevent systemic 
cortisol from becoming elevated.  
When comparing the levels of mRNA and the activity of 11-BHSD1 in converting 
cortisone to cortisol, there was a higher ratio of activity to mRNA level in omental adipose tissue 
than in subcutaneous.35 Veilleux et al. found that increased activity of 11-BHSD1 in omental 
adipose tissue was associated with increased VAT, independent of BMI, and that adipocyte size 
was the most significant predictor of activity.53 This reinforces the concept that GCs’ effects on 
adipose tissue are self-perpetuating. As GCs stimulate adipogenesis, increased VAT generates 
changes in their production within adipose tissue.  
Because changes in 11-BHSD1 activity did not always directly follow changes in mRNA 
levels, both authors posit that there are post-translational mechanisms at work that are impacting 
the activity in omental tissue. The activity of hexose-6-phosphate dehydrogenase, which 
catalyzes the formation of NADPH in the endoplasmic reticulum necessary for the 11-BHSD1 
reaction to occur, is implicated.35  
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The role of the GC receptor  
The two types of GC receptor, GR (type 2, NR3C1) and MR (type 1, NR3C2) mediate 
genomic and non-genomic actions in the peripheral tissues as they do in central regulation.36 The 
action of GCs thus depends not only on the local interconversion of metabolites, and the tissue 
type, as described above, but also the ratio of GR to MR and their intracellular environment.14,34 
Through knock down of the GR and MR receptors in human pre-adipocytes using RNA 
interference, Lee and Fried demonstrated that the effects of GCs on adipocyte differentiation are 
likely mediated through the GR, though contrasting results have been found in mouse 
preadipocytes.34 They also found that though both receptor types were expressed in both 
preadipocytes and adipocytes, the GR mRNA levels were much higher than MR mRNA levels. 
However, the expression of MR was increased with obesity, so that the relative importance of 
each may be different once obesity is present.34  
 Extending the study of GR action, de Kloet et al. investigated the response of GC levels 
to stress in the context of a normal or knocked down adipocyte GR in mice. The GR knock down 
mice had higher GC as well as blood glucose levels in response to stress. When given 
dexamethasone to induce negative feedback on the HPA axis prior to stress exposure, the knock 
down mice displayed less inhibition than the normal mice. These results were shown in non-
obese, metabolically normal mice, so the changes observed appear to precede any changes in 
weight status.14 This indicates the importance of the GR in maintaining normal signaling to the 
HPA axis from the periphery.  
 
Other hormonal and neuronal signals impacting HPA axis activity  
 21 
The PVN receives neuronal input from the arcuate nucleus (ARC) within the hypothalamus, 
which relays the information it receives from the periphery.57 In homeostatic regulation of 
energy intake, it does so through first order neurons, either POMC neurons, which transmit 
anorexigenic signals, or NPY/AgRP neurons, which transmit orexigenic signals to second order 
neurons in the PVN or lateral hypothalamus.22 Many signals from the periphery are integrated 
centrally in such a manner to communicate local conditions and intake needs; leptin and ghrelin 
will be addressed here. NPY, also addressed, mediates these hormonal signals centrally, is 
released independently in response to stress, and may be generated peripherally. 
 
Neuropeptide Y  
NPY is an orexigenic peptide with various receptor isoforms identified in the brain.33 Its 
central activity appears to be influenced by other signals from the periphery that indicate energy 
status. Insulin and leptin, anorexigenic signals, lower the expression of NPY in the 
hypothalamus.18 Leptin deficient mice normally display an obese phenotype and hyperphagia, 
but these effects are reduced with knock out of the NPY2 receptor gene.33 And NPY antagonists 
reduce the capacity of ghrelin to initiate feeding in the ARC.44  
NPY may also have peripheral effects in adipose tissue that work in coordination with the 
activity of the HPA axis in response to stressful stimuli. GCs increase NPY levels and expression 
of both NPY and NPY2 receptors in abdominal adipose tissue, as well as in sympathetic 
nerves.33 Some NPY in circulation is likely produced by peripheral tissues including 
adipocytes.33 And mouse preadipocytes cultured with NPY showed increased NPY2 receptor 
expression. These preadipocytes also had increased proliferation, angiogenesis, and 
differentiation.33 Adipose tissue volume and weight in lean and obese mice increased by 50% 
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when they were exposed to NPY through a pellet in their subcutaneous abdominal tissue, while 
adipose tissue volume and weight decreased by 50% with exposure to an NPY receptor 
antagonist. Similar decreases were seen in mice with stressor-induced elevations in NPY 
exposed to calorically rich diets that were given NPY receptor antagonists. NPY2 receptor knock 
out mice were similarly resistant to the effects of chronic stress and diet to increase adiposity.33 
Thus, NPY activity appears to be necessary for coordinated diet and stress-induced VAT 
accumulation. Ailanen et al. developed these results further, finding that without elevated NPY, 
receptor antagonists did not positively impact diet-induced obesity, and in fact worsened 
metabolic outcomes.1 This implies their potential utility in obesity treatment would be limited to 
those with elevated NPY, but that they could be a means of tailoring treatment to those with 
stress and obesity. 
 
Leptin 
A peptide produced primarily by and proportionately to white adipose tissue, leptin is an 
anorexigenic signal that suppresses appetite and lipogenesis, as well as acting on a host of other 
physiological functions.43 Leptin likely interacts directly with multiple regions of the 
hypothalamus, as mRNA for its receptors is widespread throughout, and in mice that cannot 
produce leptin, as well as in humans with leptin deficiencies, HPA axis activity is increased. 
Additional rodent studies have shown that leptin likely acts to control CRF release in the PVN 
and ARC, and leptin receptor mRNA has been identified in both the adrenal and pituitary glands, 
so it may act on those components of the HPA axis as well.43  
 As with obesity, where systemic leptin is elevated, leptin levels change with chronic 
exposure to stress. Yet conversely, stress is associated with lower levels of leptin. In a human 
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study by Jaremka et al., women reporting a higher number of both acute and chronic stressful 
interpersonal interactions had lower levels of leptin than those reporting fewer interpersonal 
stressors.29 Non-interpersonal stressors, however, showed no association with leptin levels, 
underlining the uniqueness of stressors related to social interaction. Food frequency 
questionnaires demonstrated that women with higher interpersonal stress exposure also had a diet 
higher in total calories, though the proportion of calories from each macronutrient type remained 
the same.29  
De Oliveira et al. confirmed significantly higher leptin levels in rats exposed to chronic 
restraint stress, and found that leptin levels peaked at the opposite time of day for stressed rats 
than controls, indicating dysregulation of normal circadian patterns, which has been previously 
linked to obesity as well as other metabolic irregularities.15,41   
Together, these results suggest a possible mechanism where stress, especially stressors 
that may be more closely tied to social and emotional connection, disrupts circadian cycles, 
causing leptin irregularity that, along with increased orexigenic signaling from NPY, leads to 
altered eating and adiposity. GCs also act directly on adipose tissue to stimulate leptin secretion, 
and they reduce central sensitivity to leptin, potentially guiding the leptin resistance seen with 
obesity.50  
 
Ghrelin 
Ghrelin is an orexigenic peptide hormone produced primarily by X/A-like cells in the 
stomach, but also by endocrine cells in the small intestine and pancreas.23 Its secretion peaks in 
anticipation of food intake. Its receptor has been identified in peripheral tissues, the 
hypothalamus, pituitary, and other regions within the brain, including on dopaminergic neurons 
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involved in the experience of reward.23,44 Within the ARC, ghrelin-activated NPY/AgRP neurons 
generate its orexigenic signal; this can be reduced but not eliminated by administration of NPY 
antagonists.44  
 Elevated ghrelin levels are associated with stress, though there appears to be differences 
in subgroups of the population defined by eating behavior. For example, binge eating disorder is 
associated with lower basal levels of ghrelin.50 The association may also depend on stress type. 
Jaremka et al. demonstrated elevated ghrelin in women only related to interpersonal stressors, 
similarly to leptin.29  
Animal studies have also shown that both chronic and acute stress can raise blood ghrelin 
levels, and that ghrelin may have a role in reducing anxiety related behavior after stress 
exposure.52 In a study in which ghrelin knock out mice were exposed to stress, the stressed knock 
out mice displayed more anxiety than wild type mice. The knock out mice also had lower levels 
of ACTH in response to stress. However, they had higher PVN activity, which indicates that 
reduced GCs as a result of reduced ACTH were not able to provide appropriate negative 
feedback. The increased PVN activity was able to be reversed by ghrelin administration.52 These 
results place the likely location of ghrelin activity on the HPA axis at the level of the pituitary. 
The authors further speculate that ghrelin reduces anxiety under stress in order to promote food 
seeking behavior.52 Elevated ghrelin may perhaps represent a means of combating catabolic 
effects of GCs during acute stress by increasing appetite and intake.50 
Like leptin, ghrelin also interacts with the reward system, so more work is needed to 
understand the boundaries of its control on homeostatic versus hedonic regulation of eating 
under stressed and non-stressed conditions.  
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Conclusions 
Stress, acute and chronic, alters the activity and reactivity of the HPA axis.6,42 Novel and 
interpersonal stressors appear particularly powerful in activating hypothalamic neurons that 
elevate downstream GC levels as compared to non-interpersonal, familiar stressors.7,32,56 
Neuroendocrine activity stimulated by stress can promote obesity and maintenance of adipose 
tissue that is less metabolically healthy.6 GCs, though generally catabolic, don’t act in isolation. 
The nutrient environment, along with conditions in the periphery, assist in determining many of 
the consequences of stress.8 The presence of insulin and NPY with GCs may be important factors 
in the development of abdominal obesity, as these cumulatively impact adipocyte differentiation, 
proliferation, and distribution among fat depots, increasing ratios of VAT to SAT.20,33,35,36,42 
Leptin, secreted primarily from adipose tissue, ghrelin, secreted primarily from the stomach, 
provide homeostatic regulation of food intake.44 Each may be disrupted with stress such that, 
along with increased NPY, central orexigenic signaling dominates anorexigenic signaling, 
increasing intake and also contributing to adiposity.6  
For adults who have experienced trauma, understanding the underlying neuroendocrine 
pathways helps isolate the physiological impact of stress from the psychosocial. The ACE study 
demonstrated that some of the health outcomes that increased as a result of exposure to adversity 
were related to what could be categorized as coping behaviors; eating, tobacco, drug, and alcohol 
use, etc.17 Attention to self-care through sleep quality, counseling, improved interpersonal 
relationships, physical activity, and healthy diet may improve weight outcomes in those with 
high ACE scores.  
However, the ACE study also found worsened health outcomes unexplained by 
behavioral factors alone.17 Some of these stress-generated changes might be able to be targeted 
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by drug therapies, lowering odds of developing some of the most burdensome chronic diseases. 
NPY receptor antagonists, administered peripherally, may have potential for limiting increases in 
VAT when elevated NPY and high energy intake is present, though they have mostly been 
studied in rodents and development of therapeutic treatments in humans would require much 
additional study.1 They may also have utility in limiting ghrelin’s orexigenic signaling.44 Given 
that interactions between GCs and insulin promote lipid accumulation, inhibitors of 11-BHSD1, 
which increases local conversion of GCs to their active form, might also help improve adipose 
tissue characteristics.20  
Obesity only develops in a subset of the population exposed to toxic stress.56 But given 
obesity’s increasing prevalence and multifactorial nature, stress remains an imperative etiology 
for further study. The study of toxic stress needs to develop methodology to better examine the 
nuances of chronic exposure to stressors. Rodent studies using more invasive methods than 
would be possible in humans can complement the use of biomarkers measured in adults and 
children exposed to stress, and cultured adipocytes can be used to study changes in peripheral 
tissues. But it is unclear whether the use of acute stressors repeated over several weeks in rodent 
studies is an appropriate proxy for chronic human stress, as rodents consistently lose weight 
when exposed to stress, while humans may lose or gain weight.27 Restraint stress, often used in 
such rodent studies, may not be adequate to model interpersonal stressors, and additional rodent 
studies using aggressive animals for stress induction, or exposing test animals to different types 
of diets as humans are, might help shed light on the nature of how stress impacts physiological 
response in the context of various environmental cues. Other animal models, including hamsters 
and non-human primates, represent a promising direction for research, as their stress axes may 
better resemble humans’.27  
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Given that trauma is often cyclical and may extend to the prenatal period through 
maternal stress, future research must encompass a longer time frame.31,50 Mechanistic stress 
response studies are often done in mature animals, so they should be extended to animals without 
complete brain development. In human cohort studies, stress-related biomarker collection and 
analysis in mother-child pairs alongside measurement of stressful psychosocial and 
environmental factors could help advance understanding of which factors significantly alter 
biomarkers, and outcomes, over time. This could highlight programmatic and policy priorities by 
helping those in public health gain insight into which developmental periods are most crucial for 
intervention. 
Finally, the study of biological mechanisms behind the association between toxic stress 
and obesity is an asset and a tool to underline the importance of a trauma-informed approach. For 
clinicians, the language of physiology may help underline the root causes of patients’ conditions 
and the need for collaboration and treatment planning that prevents additional trauma from being 
inflicted. But the complexity of the association between physical health and childhood trauma, 
along with the scope of the potential impact, demands action in multiple directions 
simultaneously. ACEs are an individual level measure of trauma, but adversity can also be 
conceived of on the family, community, and societal levels.50,56 Mitigation of toxic stress can 
occur on these levels, through supportive child care and educational settings, federal programs 
that relieve household stress, and reduction of discrimination and the impacts of historical 
traumas.45,47 The fields of developmental psychology, neuroscience, endocrinology, biochemistry 
and public health must all come together in order to address the issue of toxic stress from a 
realistic, actionable, and “whole-person” perspective. 
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